Sessa Capital Im, L.P. Allogene Therapeutics, Inc. Transaction History

Sessa Capital Im, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$7.65 - $15.29 $2.56 Million - $5.11 Million	-334,396 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$13.13 - $24.52 $5.46 Million - $10.2 Million	-415,604 Reduced 55.41%	334,396 $4.99 Million
Q2 2021 Aug 16, 2021	BUY	$23.49 - $35.8 $17.6 Million - $26.8 Million	750,000 New	750,000 $19.6 Million

163

134M

59.4K

113K

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $296M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

Get notified when there are updates to the investment portfolio of Sessa Capital Im, L.P., based on Form 13F filings with the SEC.

Stay updated on Sessa Capital Im, L.P. with notifications on news.